Literature DB >> 31481327

Epidemiology, Comorbidities, and Outcomes of Posterior Reversible Encephalopathy Syndrome in Children in the United States.

Aravind Thavamani1, Krishna Kishore Umapathi2, Mammen Puliyel3, Dennis Super4, Veerajalandhar Allareddy5, Abdulla Ghori1.   

Abstract

BACKGROUND: Posterior reversible encephalopathy syndrome (PRES) is an increasingly recognized entity with certain identified predisposing factors in children. However, the actual incidence, comorbidities, outcomes, and hospitalization charges among children (aged less than 20 years) in the United States are largely unknown.
METHODS: We analyzed the Kids' Inpatient Database for incidence of PRES-related hospitalizations, associated diagnoses, in-hospital outcomes, and charges for children in the United States in 2016. We report demographics, risk factors, discharge status, mortality, length of stay, and hospitalization charges.
RESULTS: In 2016, 825 pediatric hospitalizations related to PRES were captured in the Kids' Inpatient Database. Hospital discharges including solid organ transplant, bone marrow transplant, hypertension, renal disorder, primary immunodeficiency, malignancy, sepsis, severe sepsis, systemic connective tissue disorder, blood transfusion, hypomagnesemia, and sickle cell anemia were queried for presence of PRES. The majority of patients were discharged home. We found that PRES-related hospitalizations were significantly associated with increased length of stay and hospitalization charges in 2016 (P < 0.001). A mortality rate of 3.2% was found in PRES-related hospitalizations when compared with 0.4% in non-PRES hospitalizations (P < 0.001).
CONCLUSION: PRES accounted for 0.04% of the hospitalizations in this database. Hypertension and the presence of a renal disorder are the most significant risk factors found to be associated with PRES. The presence of PRES was associated with a significant increase in hospitalization charges and increased length of stay.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Incidence; Kids Inpatient Database; Outcomes; PRES; Posterior reversible encephalopathy syndrome; Vasogenic edema

Year:  2019        PMID: 31481327     DOI: 10.1016/j.pediatrneurol.2019.07.007

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  9 in total

1.  Clinical features, predictors and outcome of posterior reversible encephalopathy syndrome (PRES) in children with hematolymphoid malignancies.

Authors:  Subramaniam Ramanathan; Vignesh Subramani; Seema Kembhavi; Maya Prasad; Nirmalya Roy Moulik; Chetan Dhamne; Gaurav Narula; Shripad Banavali
Journal:  Childs Nerv Syst       Date:  2022-05-25       Impact factor: 1.532

Review 2.  Etiology and clinical characteristics of pediatric non-neoplastic posterior reversible encephalopathy: systematic review.

Authors:  Mariana Jordão; Pedro Raimundo; Ruben Jacinto; Daniel Garrido; João Martins; Rui Estevens; Jerina Nogueira; Emanuel Fernandes; Ana Macedo; Hipólito Nzwalo
Journal:  Porto Biomed J       Date:  2022-06-17

3.  Different Clinicoradiological Characteristics of Posterior Reversible Encephalopathy Syndrome in Pediatric Oncology and Post-Bone Marrow Transplantation Cases: A Retrospective Study.

Authors:  Hwazen Shash; Saad Aldaama; Hala Omer; Sameera Alafghani
Journal:  Front Neurol       Date:  2022-05-06       Impact factor: 4.086

4.  Posterior Reversible Encephalopathy Syndrome: Incidence and Clinical Characteristics in Children With Cancer.

Authors:  Katherine R Sommers; Jodi Skiles; Brian Leland; Courtney M Rowan
Journal:  J Pediatr Hematol Oncol       Date:  2022-03-01       Impact factor: 1.170

5.  Clinico-radiological Profile of Posterior Reversible Encephalopathy Syndrome and Its Associated Risk Factors in PICU: A Single-center Experience from a Tertiary Care Hospital in Bhubaneswar, Odisha.

Authors:  Chinmay K Behera; Mukesh K Jain; Reshmi Mishra; Pratap K Jena; Santosh K Dash; Ranjan K Sahoo
Journal:  Indian J Crit Care Med       Date:  2020-12

6.  Posterior reversible encephalopathy syndrome (PRES) in a 6-year-old child with nephrotic syndrome.

Authors:  Alessandra Marinari; Anthea Bottoni; Luca Stoppino; Gianpaolo Grilli; Lucia Soldano; Anna Calò; Matilde Cioccia; Giuseppina Mongelli; Barbara Santangelo; Felice Sica; Angelo Campanozzi
Journal:  Radiol Case Rep       Date:  2020-11-13

7.  Management and Clinical Outcome of Posterior Reversible Encephalopathy Syndrome in Pediatric Oncologic/Hematologic Diseases: A PRES Subgroup Analysis With a Large Sample Size.

Authors:  Marady Hun; Min Xie; Zhou She; Amin S Abdirahman; Cuifang Li; Feifeng Wu; Senlin Luo; Phanna Han; Rithea Phorn; Pan Wu; Haiyan Luo; Keke Chen; Jidong Tian; Wuqing Wan; Chuan Wen
Journal:  Front Pediatr       Date:  2021-07-01       Impact factor: 3.418

8.  Long-Term Follow-Up of Patients with a Diagnosis of Posterior Reversible Encephalopathy Syndrome.

Authors:  Mehmet Canpolat; Gül Demet Kaya Özçora; Hakan Poyrazoğlu; Huseyin Per; Abdulhakim Çoşkun; Hakan Gümüş; Duran Arslan; Ekrem Ünal; Musa Karakükçü; Türkan Patıroğlu; Sefer Kumandaş
Journal:  Turk Arch Pediatr       Date:  2021-11

Review 9.  Posterior Reversible Encephalopathy Syndrome: A Review of the Literature.

Authors:  Yuya Ando; Yosuke Ono; Azusa Sano; Naoya Fujita; Sachiko Ono
Journal:  Intern Med       Date:  2021-07-17       Impact factor: 1.271

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.